Literature DB >> 25110338

Prediction of costs and length of stay in coronary artery bypass grafting.

Ruben L Osnabrugge1, Alan M Speir2, Stuart J Head1, Philip G Jones3, Gorav Ailawadi4, Clifford E Fonner5, Edwin Fonner6, A Pieter Kappetein1, Jeffrey B Rich7.   

Abstract

BACKGROUND: Although more than 200,000 bypass operations are performed in the United States annually, few data exist on the predictors of costs and resource use for this procedure. Questions related to clinical outcomes, costs, and resource use in coronary artery bypass grafting (CABG) were addressed.
METHODS: In a multiinstitutional statewide database, patient level data from 42,839 patients undergoing isolated CABG were combined with cost data. After adjustment for cost-to-charge ratios and inflation, the association of length of stay and costs with the Society of Thoracic Surgeons-Predicted Risk of Mortality (STS-PROM) was analyzed. Patients were randomly divided into development (60%) and validation (40%) cohorts. Regression models were developed to analyze the impact of patient characteristics, comorbidities, and adverse events on postoperative length of stay and total costs.
RESULTS: Postoperative length of stay and total direct costs for CABG averaged 6.9 days and $38,847. Length of stay and costs increased from 5.4 days and $33,275 in the lowest-risk decile (mean STS-PROM of 0.6%) to 13.8 days and $69,122 in the highest-risk decile (mean STS-PROM 19%). Compared with adverse events, patient characteristics had little impact on length of stay and costs. on validation, the models that combined preoperative and postoperative variables explained variance better (R(2) = 0.51 for length of stay; R(2) = 0.47 for costs) and were better calibrated than the preoperative models (R(2) = 0.10 for length of stay; R(2) = 0.14 for costs).
CONCLUSIONS: The STS-PROM and preoperative regression models are useful for preoperative prediction of costs and length of stay for groups of patients, case-mix adjustment in hospital benchmarking, and pay for performance measures. The combined preoperative and postoperative models identify incremental costs and length of stay associated with adverse events and are more suitable for prioritizing quality improvement efforts.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25110338     DOI: 10.1016/j.athoracsur.2014.05.073

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Minimally invasive mitral valve surgery is associated with excellent resource utilization, cost, and outcomes.

Authors:  Robert B Hawkins; J Hunter Mehaffey; Samuel M Kessel; Jolian J Dahl; Irving L Kron; John A Kern; Leora T Yarboro; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-03       Impact factor: 5.209

2.  Effects of Preoperative Risk Stratification on Direct In-hospital Costs for Chinese Patients with Coronary Artery Bypass Graft: A Single Center Analysis.

Authors:  Mei Yang; Jia Hao; Zhao Jian; Ying-Bin Xiao; Lai-Xin Zhou
Journal:  Curr Med Sci       Date:  2018-12-07

3.  Predicted Risk of Mortality Score predicts 30-day readmission after coronary artery bypass grafting.

Authors:  Joshua M Rosenblum; Brendan P Lovasik; John C Hunting; Jose Binongo; Michael E Halkos; Bradley G Leshnower; Jeffrey S Miller; Omar M Lattouf; Robert A Guyton; William B Keeling
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-08

4.  Outcomes and Costs of Cardiac Surgery in Adults with Congenital Heart Disease.

Authors:  Viviane G Nasr; David Faraoni; Anne Marie Valente; James A DiNardo
Journal:  Pediatr Cardiol       Date:  2017-07-01       Impact factor: 1.655

5.  The Impact of the Medicaid Healthcare-Associated Condition Program on Mediastinitis Following Coronary Artery Bypass Graft.

Authors:  Heather E Hsu; Alison Tse Kawai; Rui Wang; Maximilian S Jentzsch; Chanu Rhee; Kelly Horan; Robert Jin; Donald Goldmann; Grace M Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2018-04-19       Impact factor: 3.254

6.  Psoas Muscle Size Predicts Risk-Adjusted Outcomes After Surgical Aortic Valve Replacement.

Authors:  Robert B Hawkins; J Hunter Mehaffey; Eric J Charles; John A Kern; D Scott Lim; Nicholas R Teman; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2018-03-09       Impact factor: 4.330

7.  Bundled Payments in Cardiac Surgery: Is Risk Adjustment Sufficient to Make It Feasible?

Authors:  Kenan W Yount; James M Isbell; Casey Lichtendahl; Zachary Dietch; Gorav Ailawadi; Irving L Kron; John A Kern; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2015-07-21       Impact factor: 4.330

8.  Pilot Study on Early Postoperative Discharge in Pituitary Adenoma Patients: Effect of Socioeconomic Factors and Benefit of Specialized Pituitary Centers.

Authors:  Christopher A Sarkiss; James Lee; Joseph A Papin; Eliza B Geer; Rudrani Banik; Janet C Rucker; Barbara Oudheusden; Satish Govindaraj; Raj K Shrivastava
Journal:  J Neurol Surg B Skull Base       Date:  2015-04-27

9.  Variability in length of stay after uncomplicated pulmonary lobectomy: is length of stay a quality metric or a patient metric?†.

Authors:  Greg P Giambrone; Matthew C Smith; Xian Wu; Licia K Gaber-Baylis; Akshay U Bhat; Ramin Zabih; Nasser K Altorki; Peter M Fleischut; Brendon M Stiles
Journal:  Eur J Cardiothorac Surg       Date:  2016-01-27       Impact factor: 4.191

10.  Physiologic assessment of moderate coronary lesions: a step towards complete revascularization in coronary artery bypass grafting.

Authors:  John C Moscona; Jason D Stencel; Gregory Milligan; Christopher Salmon; Rohit Maini; Paul Katigbak; Qusai Saleh; Ryan Nelson; Sudesh Srivastav; Owen Mogabgab; Rohan Samson; Thierry Le Jemtel
Journal:  Ann Transl Med       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.